The global real-time PCR, digital PCR, and end-point PCR market size is expected to reach USD 7.18 billion by 2030, registering a CAGR of 4.2% from 2024 to 2030. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2023 to 2030. Digital PCR is a novel technique for absolute quantification and analysis of minority sequences in the presence of similar majority sequences. dPCR allows for precise and sensitive nucleic acid measurement. In addition, real-time PCR provides precise and early diagnosis of diseases and rapid and targeted patient care hence anticipated to increase the demand in the coming years ![Global Real-time PCR, Digital PCR, and End-point PCR Market]( "Global Real-time PCR, Digital PCR, and End-point PCR Market")
The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.
Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.
Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.
Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period.
The rise in the occurrence of diseases such as lung cancer, blood cancer, and brain tumors is fueling the application expansion of the global market. According to Globocan 2020, lung cancer is the second most common cancer in Europe, with an estimated 477,534 newly diagnosed cases. Furthermore, the benefits of digital polymerase chain reaction over traditional technologies such as real-time and quantitative polymerase chain reaction are likely to drive adoption throughout the forecast period. Moreover, rising healthcare expenditures in emerging nations and the increased need for accurate molecular disease detection are propelling the market growth.
Furthermore, the COVID-19 pandemic has increased the demand for digital PCR instruments and reagents. COVID-19 infections are detected using modern digital PCR instruments as a molecular diagnosis technique. According to the WHO, around 273 million cases have been diagnosed and roughly 5.3 million deaths have been documented worldwide due to COVID-19 as of December 2021. Moreover, in the pharmaceutical industry, digital PCR machines are also employed in R&D.
Furthermore, advancements in technology and an increase in the number of product launches in the global market are expected to support the market growth. For instance, in June 2021, Bio-Rad Laboratories, Inc. announced the release of the PREvalence ddPCR SARS-CoV-2 waste-water quantifying kit for COVID-19 wastewater screening.
Additionally, the increase in R&D projects for advancements in technology and an increase in collaborations between firms for the development of digital polymerase chain reactions are expected to increase the usage of PCR testing. For instance, Qiagen partnered with Atila BioSystems & Actome GmbH in January 2022 to deliver non-invasive prenatal testing (NIPT) technologies to QIAGEN's dPCR for a growing number of applications for QIAcuity. As a result, the usage of real-time and digital PCR technologies is projected to increase during the forecast period.
Real-time PCR, Digital PCR, And End-point PCR Market Report Highlights
- By technology, the Quantitative PCR segment held largest revenue share of over 83.34% in 2023. This is attributed to the high adoption of technology supported by the introduction of products based on real-time polymerase chain reaction for screening and diagnosis of COVID-19
- The consumables and reagents segment held the largest revenue share of over 62.62% in 2023 due to the increased demand for earlier detection and the number of significant companies manufacturing digital PCR consumables and reagents
- North America dominated the market with a revenue share of over 35.94% in 2023 due to the presence of high R&D investment, the availability of a technologically advanced healthcare research framework, the strong presence of prominent polymerase chain reaction manufacturers, and an expanding requirement for rapid diagnostic tests in the region
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation
1.1.1 Product Segment
1.1.2 Technology Segment
1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
1.1.1 Product Segment
1.1.2 Technology Segment
1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates And Forecast Timeline
1.4 Objectives
1.4.1 Objective - 1
1.4.2 Objective - 2
1.4.3 Objective - 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 Internal database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information Or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Summary
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Real-time PCR (qPCR) Market - Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
3.2.1.2 Technological advancements in PCR
3.2.1.3 Implementation of MIQE guidelines
3.2.1.4 Increasing demand for rapid diagnostic tests and growing adoption of qPCR & dPCR technologies
3.2.1.5 Increasing number of CROs and forensic & research laboratories
3.2.1.6 Increasing demand for prenatal genetic testing procedures
3.2.2 Market Restraint Analysis
3.2.2.1 High device costs associated with Real time PCR (qPCR)
3.2.2.2 Stringent regulatory policies
3.3 Comparative Analysis
3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis - Porter’s
3.1.1 Parent Market Lineage Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Rising incidence of chronic diseases, infectious diseases, and genetic disorders
3.2.1.2 Technological advancements in PCR
3.2.1.3 Implementation of MIQE guidelines
3.2.1.4 Increasing demand for rapid diagnostic tests and growing adoption of qPCR & dPCR technologies
3.2.1.5 Increasing number of CROs and forensic & research laboratories
3.2.1.6 Increasing demand for prenatal genetic testing procedures
3.2.2 Market Restraint Analysis
3.2.2.1 High device costs associated with Real time PCR (qPCR)
3.2.2.2 Stringent regulatory policies
3.3 Comparative Analysis
3.4 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis - Porter’s
Chapter 4 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Technology Scope, 2018-2030 (Revenue, USD Million)
4.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Technology Movement Analysis
4.2 Quantitative
4.2.1 Quantitative Market Estimates And Forecast, 2018-2030 (USD Million)
4.2.2 Consumables & Reagents
4.2.2.1 Consumables & Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
4.2.3 Instruments
4.2.3.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
4.2.4 Software & Services
4.2.4.1 Software & Services Market Estimates And Forecast, 2018-2030 (USD Million)
4.3 Digital
4.3.1 Digital Market Estimates And Forecast, 2018-2030 (USD Million)
4.3.2 Consumables & Reagents
4.3.2.1 Consumables & Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
4.3.3 Instruments
4.3.3.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
4.3.4 Software & Services
4.3.4.1 Software & Services Market Estimates And Forecast, 2018-2030 (USD Million)
4.4 End-Point Pcr
4.4.1 End-Point Pcr Market Estimates And Forecast, 2018-2030 (USD Million)
4.4.2 Consumables & Reagents
4.4.2.1 Consumables & Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
4.4.3 Instruments
4.4.3.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
4.4.4 Software & Services
4.4.4.1 Software & services market estimates and forecast, 2018-2030 (USD Million)
4.2 Quantitative
4.2.1 Quantitative Market Estimates And Forecast, 2018-2030 (USD Million)
4.2.2 Consumables & Reagents
4.2.2.1 Consumables & Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
4.2.3 Instruments
4.2.3.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
4.2.4 Software & Services
4.2.4.1 Software & Services Market Estimates And Forecast, 2018-2030 (USD Million)
4.3 Digital
4.3.1 Digital Market Estimates And Forecast, 2018-2030 (USD Million)
4.3.2 Consumables & Reagents
4.3.2.1 Consumables & Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
4.3.3 Instruments
4.3.3.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
4.3.4 Software & Services
4.3.4.1 Software & Services Market Estimates And Forecast, 2018-2030 (USD Million)
4.4 End-Point Pcr
4.4.1 End-Point Pcr Market Estimates And Forecast, 2018-2030 (USD Million)
4.4.2 Consumables & Reagents
4.4.2.1 Consumables & Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
4.4.3 Instruments
4.4.3.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
4.4.4 Software & Services
4.4.4.1 Software & services market estimates and forecast, 2018-2030 (USD Million)
Chapter 5 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Product Scope, 2018-2030 (Revenue, USD Million)
5.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Products Movement Analysis
5.2 Consumables & Reagents
5.2.1 Consumables & Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
5.3 Instruments
5.3.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
5.4 Software & Services
5.4.1 Software & Services Market Estimates And Forecast, 2018-2030 (USD Million)
5.2 Consumables & Reagents
5.2.1 Consumables & Reagents Market Estimates And Forecast, 2018-2030 (USD Million)
5.3 Instruments
5.3.1 Instruments Market Estimates And Forecast, 2018-2030 (USD Million)
5.4 Software & Services
5.4.1 Software & Services Market Estimates And Forecast, 2018-2030 (USD Million)
Chapter 6 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Application Scope, 2018-2030 (Revenue, USD Million)
6.1 Real-time PCR (qPCR), end point PCR, and dPCR Market: Application Movement Analysis
6.2 Clinical
6.2.1 Clinical Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2 Pathogen Testing
6.2.2.1 Pathogen Testing Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.3 Oncology Testing
6.2.3.1 Oncology Testing Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.4 Blood Screening
6.2.4.1 Blood Screening Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.5 Liquid Biopsy Testing
6.2.5.1 Liquid Biopsy Testing Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.6 Dpcr-Based Non-Invasive Prenatal Testing (Nipt)
6.2.6.1 Dpcr-Based Non-Invasive Prenatal Testing (Nipt) Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.7 Others
6.2.7.1 Others Market Estimates And Forecast, 2018-2030 (USD Million)
6.3 Research
6.3.1 Research Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2 Stem Cell Research
6.3.2.1 Stem Cell Research Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.3 Dna Cloning & Sequencing
6.3.3.1 Dna Cloning & Sequencing Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.4 Recombinant Dna Technology
6.3.4.1 Recombinant Dna Technology Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.5 Rare Mutation Detection
6.3.5.1 Rare Mutation Detection Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.6 Gene Expression
6.3.6.1 Gene Expression Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.7 Single-Cell Analysis
6.3.7.1 Single-Cell Analysis Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.8 Microbiome Analysis
6.3.8.1 Microbiome Analysis Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.9 Copy Number Variation Analysis
6.3.9.1 Copy Number Variation Analysis Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.10 Library Quantification (Ngs)
6.3.10.1 Library Quantification (Ngs) Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.11 Characterization Of Low-Fold Changes In Mrna And Mirna Expression
6.3.11.1 Characterization Of Low-Fold Changes In Mrna And Mirna Expression Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.12 Species Identification
6.3.12.1 Species identification market estimates and forecast, 2018-2030 (USD Million)
6.3.13 GMO Detection
6.3.13.1 GMO detection market estimates and forecast, 2018-2030 (USD Million)
6.4 Forensics and Others
6.4.1.1 Forensics and others market estimates and forecast, 2018-2030 (USD Million)
6.2 Clinical
6.2.1 Clinical Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.2 Pathogen Testing
6.2.2.1 Pathogen Testing Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.3 Oncology Testing
6.2.3.1 Oncology Testing Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.4 Blood Screening
6.2.4.1 Blood Screening Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.5 Liquid Biopsy Testing
6.2.5.1 Liquid Biopsy Testing Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.6 Dpcr-Based Non-Invasive Prenatal Testing (Nipt)
6.2.6.1 Dpcr-Based Non-Invasive Prenatal Testing (Nipt) Market Estimates And Forecast, 2018-2030 (USD Million)
6.2.7 Others
6.2.7.1 Others Market Estimates And Forecast, 2018-2030 (USD Million)
6.3 Research
6.3.1 Research Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.2 Stem Cell Research
6.3.2.1 Stem Cell Research Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.3 Dna Cloning & Sequencing
6.3.3.1 Dna Cloning & Sequencing Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.4 Recombinant Dna Technology
6.3.4.1 Recombinant Dna Technology Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.5 Rare Mutation Detection
6.3.5.1 Rare Mutation Detection Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.6 Gene Expression
6.3.6.1 Gene Expression Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.7 Single-Cell Analysis
6.3.7.1 Single-Cell Analysis Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.8 Microbiome Analysis
6.3.8.1 Microbiome Analysis Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.9 Copy Number Variation Analysis
6.3.9.1 Copy Number Variation Analysis Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.10 Library Quantification (Ngs)
6.3.10.1 Library Quantification (Ngs) Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.11 Characterization Of Low-Fold Changes In Mrna And Mirna Expression
6.3.11.1 Characterization Of Low-Fold Changes In Mrna And Mirna Expression Market Estimates And Forecast, 2018-2030 (USD Million)
6.3.12 Species Identification
6.3.12.1 Species identification market estimates and forecast, 2018-2030 (USD Million)
6.3.13 GMO Detection
6.3.13.1 GMO detection market estimates and forecast, 2018-2030 (USD Million)
6.4 Forensics and Others
6.4.1.1 Forensics and others market estimates and forecast, 2018-2030 (USD Million)
Chapter 7 Real-time PCR (qPCR), end point PCR, and dPCR Market Analysis, Regional Scope, 2018-2030 (Revenue, USD Million)
7.1 Market Share Analysis by Country, 2023 & 2030
7.1.1 North America
7.1.1.1 North America market estimates and forecast, 2018-2030 (USD Million)
7.1.1.2 U.S.
7.1.1.2.1 U.S. market estimates and forecast, 2018-2030 (USD Million)
7.1.1.2.2 Key country dynamics
7.1.1.2.3 Competitive scenario
7.1.1.2.4 Regulatory framework
7.1.1.3 Canada
7.1.1.3.1 Canada market estimates and forecast, 2018-2030 (USD Million)
7.1.1.3.2 Key country dynamics
7.1.1.3.3 Competitive scenario
7.1.1.3.4 Regulatory framework
7.1.2 Europe
7.1.2.1 Europe market estimates and forecast, 2018-2030 (USD Million)
7.1.2.2 UK
7.1.2.2.1 UK market estimates and forecast, 2018-2030 (USD Million)
7.1.2.2.2 Key country dynamics
7.1.2.2.3 Competitive scenario
7.1.2.2.4 Regulatory framework
7.1.2.3 Germany
7.1.2.3.1 Germany market estimates and forecast, 2018-2030 (USD Million)
7.1.2.3.2 Key country dynamics
7.1.2.3.3 Competitive scenario
7.1.2.3.4 Regulatory framework
7.1.2.4 France
7.1.2.4.1 France market estimates and forecast, 2018-2030 (USD Million)
7.1.2.4.2 Key country dynamics
7.1.2.4.3 Competitive scenario
7.1.2.4.4 Regulatory framework
7.1.2.5 Italy
7.1.2.5.1 Italy market estimates and forecast, 2018-2030 (USD Million)
7.1.2.5.2 Key country dynamics
7.1.2.5.3 Competitive scenario
7.1.2.5.4 Regulatory framework
7.1.2.6 Spain
7.1.2.6.1 Spain market estimates and forecast, 2018-2030 (USD Million)
7.1.2.6.2 Key country dynamics
7.1.2.6.3 Competitive scenario
7.1.2.6.4 Regulatory framework
7.1.2.7 Denmark
7.1.2.7.1 Denmark market estimates and forecast, 2018-2030 (USD Million)
7.1.2.7.2 Key country dynamics
7.1.2.7.3 Competitive scenario
7.1.2.7.4 Regulatory framework
7.1.2.8 Sweden
7.1.2.8.1 Sweden market estimates and forecast, 2018-2030 (USD Million)
7.1.2.8.2 Key country dynamics
7.1.2.8.3 Competitive scenario
7.1.2.8.4 Regulatory framework
7.1.2.9 Norway
7.1.2.9.1 Norway market estimates and forecast, 2018-2030 (USD Million)
7.1.2.9.2 Key country dynamics
7.1.2.9.3 Competitive scenario
7.1.2.9.4 Regulatory framework
7.1.3 Asia-Pacific
7.1.3.1 Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
7.1.3.2 Japan
7.1.3.2.1 Japan market estimates and forecast, 2018-2030 (USD Million)
7.1.3.2.2 Key country dynamics
7.1.3.2.3 Competitive scenario
7.1.3.2.4 Regulatory framework
7.1.3.3 India
7.1.3.3.1 India market estimates and forecast, 2018-2030 (USD Million)
7.1.3.3.2 Key country dynamics
7.1.3.3.3 Competitive scenario
7.1.3.3.4 Regulatory framework
7.1.3.4 Australia
7.1.3.4.1 Australia market estimates and forecast, 2018-2030 (USD Million)
7.1.3.4.2 Key country dynamics
7.1.3.4.3 Competitive scenario
7.1.3.4.4 Regulatory framework
7.1.3.5 China
7.1.3.5.1 China market estimates and forecast, 2018-2030 (USD Million)
7.1.3.5.2 Key country dynamics
7.1.3.5.3 Competitive scenario
7.1.3.5.4 Regulatory framework
7.1.3.6 South Korea
7.1.3.6.1 South Korea market estimates and forecast, 2018-2030 (USD Million)
7.1.3.6.2 Key country dynamics
7.1.3.6.3 Competitive scenario
7.1.3.6.4 Regulatory framework
7.1.3.7 Thailand
7.1.3.7.1 Thailand market estimates and forecast, 2018-2030 (USD Million)
7.1.3.7.2 Key country dynamics
7.1.3.7.3 Competitive scenario
7.1.3.7.4 Regulatory framework
7.1.4 Latin America
7.1.4.1 Latin America market estimates and forecast, 2018-2030 (USD Million)
7.1.4.2 Brazil
7.1.4.2.1 Brazil market estimates and forecast, 2018-2030 (USD Million)
7.1.4.2.2 Key country dynamics
7.1.4.2.3 Competitive scenario
7.1.4.2.4 Regulatory framework
7.1.4.3 Mexico
7.1.4.3.1 Mexico market estimates and forecast, 2018-2030 (USD Million)
7.1.4.3.2 Key country dynamics
7.1.4.3.3 Competitive scenario
7.1.4.3.4 Regulatory framework
7.1.4.4 Argentina
7.1.4.4.1 Argentina market estimates and forecast, 2018-2030 (USD Million)
7.1.4.4.2 Key country dynamics
7.1.4.4.3 Competitive scenario
7.1.4.4.4 Regulatory framework
7.1.5 Middle East & Africa
7.1.5.1 Middle East & Africa market estimates and forecast, 2018-2030 (USD Million)
7.1.5.2 South Africa
7.1.5.2.1 South Africa market estimates and forecast, 2018-2030 (USD Million)
7.1.5.2.2 Key country dynamics
7.1.5.2.3 Competitive scenario
7.1.5.2.4 Regulatory framework
7.1.5.3 Saudi Arabia
7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
7.1.5.3.2 Key country dynamics
7.1.5.3.3 Competitive scenario
7.1.5.3.4 Regulatory framework
7.1.5.4 UAE
7.1.5.4.1 UAE market estimates and forecast, 2018-2030 (USD Million)
7.1.5.4.2 Key country dynamics
7.1.5.4.3 Competitive scenario
7.1.5.4.4 Regulatory framework
7.1.5.5 Kuwait
7.1.5.5.1 Kuwait market estimates and forecast, 2018-2030 (USD Million)
7.1.5.5.2 Key country dynamics
7.1.5.5.3 Competitive scenario
7.1.5.5.4 Regulatory framework
7.1.1 North America
7.1.1.1 North America market estimates and forecast, 2018-2030 (USD Million)
7.1.1.2 U.S.
7.1.1.2.1 U.S. market estimates and forecast, 2018-2030 (USD Million)
7.1.1.2.2 Key country dynamics
7.1.1.2.3 Competitive scenario
7.1.1.2.4 Regulatory framework
7.1.1.3 Canada
7.1.1.3.1 Canada market estimates and forecast, 2018-2030 (USD Million)
7.1.1.3.2 Key country dynamics
7.1.1.3.3 Competitive scenario
7.1.1.3.4 Regulatory framework
7.1.2 Europe
7.1.2.1 Europe market estimates and forecast, 2018-2030 (USD Million)
7.1.2.2 UK
7.1.2.2.1 UK market estimates and forecast, 2018-2030 (USD Million)
7.1.2.2.2 Key country dynamics
7.1.2.2.3 Competitive scenario
7.1.2.2.4 Regulatory framework
7.1.2.3 Germany
7.1.2.3.1 Germany market estimates and forecast, 2018-2030 (USD Million)
7.1.2.3.2 Key country dynamics
7.1.2.3.3 Competitive scenario
7.1.2.3.4 Regulatory framework
7.1.2.4 France
7.1.2.4.1 France market estimates and forecast, 2018-2030 (USD Million)
7.1.2.4.2 Key country dynamics
7.1.2.4.3 Competitive scenario
7.1.2.4.4 Regulatory framework
7.1.2.5 Italy
7.1.2.5.1 Italy market estimates and forecast, 2018-2030 (USD Million)
7.1.2.5.2 Key country dynamics
7.1.2.5.3 Competitive scenario
7.1.2.5.4 Regulatory framework
7.1.2.6 Spain
7.1.2.6.1 Spain market estimates and forecast, 2018-2030 (USD Million)
7.1.2.6.2 Key country dynamics
7.1.2.6.3 Competitive scenario
7.1.2.6.4 Regulatory framework
7.1.2.7 Denmark
7.1.2.7.1 Denmark market estimates and forecast, 2018-2030 (USD Million)
7.1.2.7.2 Key country dynamics
7.1.2.7.3 Competitive scenario
7.1.2.7.4 Regulatory framework
7.1.2.8 Sweden
7.1.2.8.1 Sweden market estimates and forecast, 2018-2030 (USD Million)
7.1.2.8.2 Key country dynamics
7.1.2.8.3 Competitive scenario
7.1.2.8.4 Regulatory framework
7.1.2.9 Norway
7.1.2.9.1 Norway market estimates and forecast, 2018-2030 (USD Million)
7.1.2.9.2 Key country dynamics
7.1.2.9.3 Competitive scenario
7.1.2.9.4 Regulatory framework
7.1.3 Asia-Pacific
7.1.3.1 Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
7.1.3.2 Japan
7.1.3.2.1 Japan market estimates and forecast, 2018-2030 (USD Million)
7.1.3.2.2 Key country dynamics
7.1.3.2.3 Competitive scenario
7.1.3.2.4 Regulatory framework
7.1.3.3 India
7.1.3.3.1 India market estimates and forecast, 2018-2030 (USD Million)
7.1.3.3.2 Key country dynamics
7.1.3.3.3 Competitive scenario
7.1.3.3.4 Regulatory framework
7.1.3.4 Australia
7.1.3.4.1 Australia market estimates and forecast, 2018-2030 (USD Million)
7.1.3.4.2 Key country dynamics
7.1.3.4.3 Competitive scenario
7.1.3.4.4 Regulatory framework
7.1.3.5 China
7.1.3.5.1 China market estimates and forecast, 2018-2030 (USD Million)
7.1.3.5.2 Key country dynamics
7.1.3.5.3 Competitive scenario
7.1.3.5.4 Regulatory framework
7.1.3.6 South Korea
7.1.3.6.1 South Korea market estimates and forecast, 2018-2030 (USD Million)
7.1.3.6.2 Key country dynamics
7.1.3.6.3 Competitive scenario
7.1.3.6.4 Regulatory framework
7.1.3.7 Thailand
7.1.3.7.1 Thailand market estimates and forecast, 2018-2030 (USD Million)
7.1.3.7.2 Key country dynamics
7.1.3.7.3 Competitive scenario
7.1.3.7.4 Regulatory framework
7.1.4 Latin America
7.1.4.1 Latin America market estimates and forecast, 2018-2030 (USD Million)
7.1.4.2 Brazil
7.1.4.2.1 Brazil market estimates and forecast, 2018-2030 (USD Million)
7.1.4.2.2 Key country dynamics
7.1.4.2.3 Competitive scenario
7.1.4.2.4 Regulatory framework
7.1.4.3 Mexico
7.1.4.3.1 Mexico market estimates and forecast, 2018-2030 (USD Million)
7.1.4.3.2 Key country dynamics
7.1.4.3.3 Competitive scenario
7.1.4.3.4 Regulatory framework
7.1.4.4 Argentina
7.1.4.4.1 Argentina market estimates and forecast, 2018-2030 (USD Million)
7.1.4.4.2 Key country dynamics
7.1.4.4.3 Competitive scenario
7.1.4.4.4 Regulatory framework
7.1.5 Middle East & Africa
7.1.5.1 Middle East & Africa market estimates and forecast, 2018-2030 (USD Million)
7.1.5.2 South Africa
7.1.5.2.1 South Africa market estimates and forecast, 2018-2030 (USD Million)
7.1.5.2.2 Key country dynamics
7.1.5.2.3 Competitive scenario
7.1.5.2.4 Regulatory framework
7.1.5.3 Saudi Arabia
7.1.5.3.1 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
7.1.5.3.2 Key country dynamics
7.1.5.3.3 Competitive scenario
7.1.5.3.4 Regulatory framework
7.1.5.4 UAE
7.1.5.4.1 UAE market estimates and forecast, 2018-2030 (USD Million)
7.1.5.4.2 Key country dynamics
7.1.5.4.3 Competitive scenario
7.1.5.4.4 Regulatory framework
7.1.5.5 Kuwait
7.1.5.5.1 Kuwait market estimates and forecast, 2018-2030 (USD Million)
7.1.5.5.2 Key country dynamics
7.1.5.5.3 Competitive scenario
7.1.5.5.4 Regulatory framework
Chapter 8 Real-time PCR (qPCR), end point PCR, and dPCR Market - Competitive Landscape
8.1 Company Categorization
8.2 Strategy Mapping
8.2.1 New Product Launch
8.2.2 Partnerships
8.2.3 Acquisition
8.2.4 Collaboration
8.2.5 Funding
8.3 Key Company Market Share Analysis, 2023
8.4 Company Profiles
8.4.1 Abbott
8.4.1.1 Company Overview
8.4.1.2 Financial Performance
8.4.1.3 Product Benchmarking
8.4.1.4 Strategic Initiatives
8.4.2 Qiagen
8.4.2.1 Company Overview
8.4.2.2 Financial Performance
8.4.2.3 Product Benchmarking
8.4.2.4 Strategic Initiatives
8.4.3 Bio-Rad Laboratories, Inc.
8.4.3.1 Company Overview
8.4.3.2 Financial Performance
8.4.3.3 Product Benchmarking
8.4.3.4 Strategic Initiatives
8.4.4 Agilent Technologies, Inc.
8.4.4.1 Company Overview
8.4.4.2 Financial Performance
8.4.4.3 Product Benchmarking
8.4.4.4 Strategic Initiatives
8.4.5 Thermo Fisher Scientific, Inc.
8.4.5.1 Company Overview
8.4.5.2 Affymetrix
8.4.5.3 Company Overview
8.4.5.4 Financial Performance
8.4.5.5 Product Benchmarking
8.4.5.6 Strategic Initiatives
8.4.6 Ge Healthcare
8.4.6.1 Company Overview
8.4.6.2 Financial Performance
8.4.6.3 Product Benchmarking
8.4.6.4 Strategic Initiatives
8.4.7 Biomérieux Sa
8.4.7.1 Company Overview
8.4.7.2 Financial Performance
8.4.7.3 Product Benchmarking
8.4.7.4 Strategic Initiatives
8.4.8 F. Hoffmann-La Roche Ltd
8.4.8.1 Company Overview
8.4.8.2 Financial Performance
8.4.8.3 Product Benchmarking
8.4.8.4 Strategic Initiatives
8.4.9 Fluidigm Corporation
8.4.9.1 Company Overview
8.4.9.2 Financial Performance
8.4.9.3 Product Benchmarking
8.4.9.4 Strategic Initiatives
8.2 Strategy Mapping
8.2.1 New Product Launch
8.2.2 Partnerships
8.2.3 Acquisition
8.2.4 Collaboration
8.2.5 Funding
8.3 Key Company Market Share Analysis, 2023
8.4 Company Profiles
8.4.1 Abbott
8.4.1.1 Company Overview
8.4.1.2 Financial Performance
8.4.1.3 Product Benchmarking
8.4.1.4 Strategic Initiatives
8.4.2 Qiagen
8.4.2.1 Company Overview
8.4.2.2 Financial Performance
8.4.2.3 Product Benchmarking
8.4.2.4 Strategic Initiatives
8.4.3 Bio-Rad Laboratories, Inc.
8.4.3.1 Company Overview
8.4.3.2 Financial Performance
8.4.3.3 Product Benchmarking
8.4.3.4 Strategic Initiatives
8.4.4 Agilent Technologies, Inc.
8.4.4.1 Company Overview
8.4.4.2 Financial Performance
8.4.4.3 Product Benchmarking
8.4.4.4 Strategic Initiatives
8.4.5 Thermo Fisher Scientific, Inc.
8.4.5.1 Company Overview
8.4.5.2 Affymetrix
8.4.5.3 Company Overview
8.4.5.4 Financial Performance
8.4.5.5 Product Benchmarking
8.4.5.6 Strategic Initiatives
8.4.6 Ge Healthcare
8.4.6.1 Company Overview
8.4.6.2 Financial Performance
8.4.6.3 Product Benchmarking
8.4.6.4 Strategic Initiatives
8.4.7 Biomérieux Sa
8.4.7.1 Company Overview
8.4.7.2 Financial Performance
8.4.7.3 Product Benchmarking
8.4.7.4 Strategic Initiatives
8.4.8 F. Hoffmann-La Roche Ltd
8.4.8.1 Company Overview
8.4.8.2 Financial Performance
8.4.8.3 Product Benchmarking
8.4.8.4 Strategic Initiatives
8.4.9 Fluidigm Corporation
8.4.9.1 Company Overview
8.4.9.2 Financial Performance
8.4.9.3 Product Benchmarking
8.4.9.4 Strategic Initiatives
List of Tables
Table 1 List of key distributors and channel partners
Table 2 List of key emerging companies’ /technology disruptors/innovators
Table 3 North America real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 4 North America real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 5 North America qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 6 North America qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 7 North America qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 8 North America real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 9 North America real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 10 North America real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 11 U.S. real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 12 U.S. real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 13 U.S. qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 14 U.S. qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 15 U.S. qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 16 U.S. real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 17 U.S. real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 18 U.S. real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 19 Canada real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 20 Canada real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 21 Canada qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 22 Canada qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 23 Canada qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 24 Canada real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 25 Canada real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 26 Canada real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 27 Europe real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 28 Europe real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 29 Europe qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 30 Europe qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 31 Europe qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 32 Europe real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 33 Europe real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 34 Europe real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 35 U.K. real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 36 U.K. real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 37 U.K. qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 38 U.K. qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 39 U.K. qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 40 U.K. real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 41 U.K. real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 42 U.K. real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 43 Germany real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 44 Germany real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 45 Germany qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 46 Germany qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 47 Germany qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 48 Germany real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 49 Germany real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 50 Germany real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 51 Italy real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 52 Italy real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 53 Italy qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 54 Italy qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 55 Italy qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 56 Italy real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 57 Italy real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 58 Italy real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 59 Spain real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 60 Spain real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 61 Spain qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 62 Spain qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 63 Spain qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 64 Spain real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 65 Spain real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 66 Spain real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 67 France real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 68 France real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 69 France qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 70 France qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 71 France qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 72 France real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 73 France real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 74 France real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 75 Denmark real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 76 Denmark real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 77 Denmark qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 78 Denmark qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 79 Denmark qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 80 Denmark real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 81 Denmark real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 82 Denmark real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 83 Sweden real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 84 Sweden real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 85 Sweden qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 86 Sweden qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 87 Sweden qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 88 Sweden real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 89 Sweden real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 90 Sweden real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 91 Norway real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 92 Norway real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 93 Norway qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 94 Norway qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 95 Norway qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 96 Norway real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 97 Norway real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 98 Norway real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 99 Asia-Pacific real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 100 Asia-Pacific real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 101 Asia-Pacific qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 102 Asia-Pacific qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 103 Asia-Pacific qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 104 Asia-Pacific real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 105 Asia-Pacific real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 106 Asia-Pacific real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 107 China real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 108 China real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 109 China qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 110 China qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 111 China qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 112 China real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 113 China real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 114 China real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 115 Japan real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 116 Japan real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 117 Japan qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 118 Japan qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 119 Japan qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 120 Japan real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 121 Japan real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 122 Japan real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 123 India real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 124 India real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 125 India qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 126 India qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 127 India qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 128 India real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 129 India real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 130 India real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 131 Australia real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 132 Australia real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 133 Australia qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 134 Australia qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 135 Australia qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 136 Australia real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 137 Australia real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 138 Australia real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 139 South Korea real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 140 South Korea real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 141 South Korea qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 142 South Korea qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 143 South Korea qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 144 South Korea real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 145 South Korea real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 146 South Korea
Table 147 Thailand real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 148 Thailand real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 149 Thailand qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 150 Thailand qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 151 Thailand qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 152 Thailand real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 153 Thailand real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 154 Thailand real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 155 Latin America real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 156 Latin America real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 157 Latin America qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 158 Latin America qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 159 Latin America qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 160 Latin America real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 161 Latin America real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 162 Latin America real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 163 Brazil real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 164 Brazil real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 165 Brazil qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 166 Brazil qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 167 Brazil qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 168 Brazil real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 169 Brazil real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 170 Brazil real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 171 Mexico real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 172 Mexico real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 173 Mexico qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 174 Mexico qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 175 Mexico qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 176 Mexico real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 177 Mexico real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 178 Mexico real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 179 Argentina real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 180 Argentina real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 181 Argentina qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 182 Argentina qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 183 Argentina qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 184 Argentina real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 185 Argentina real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 186 Argentina real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 187 MEA real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 188 MEA real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 189 MEA qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 190 MEA qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 191 MEA qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 192 MEA real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 193 MEA real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 194 MEA real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 195 South Africa real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 196 South Africa real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 197 South Africa qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 198 South Africa qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 199 South Africa qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 200 South Africa real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 201 South Africa real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 202 South Africa real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 203 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 204 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 205 Saudi Arabia qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 206 Saudi Arabia qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 207 Saudi Arabia qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 208 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 209 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 210 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 211 UAE real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 212 UAE real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 213 UAE qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 214 UAE qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 215 UAE qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 216 UAE real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 217 UAE real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 218 UAE real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 219 Kuwait real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 220 Kuwait real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 221 Kuwait qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 222 Kuwait qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 223 Kuwait qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 224 Kuwait real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 225 Kuwait real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 226 Kuwait real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 2 List of key emerging companies’ /technology disruptors/innovators
Table 3 North America real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 4 North America real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 5 North America qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 6 North America qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 7 North America qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 8 North America real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 9 North America real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 10 North America real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 11 U.S. real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 12 U.S. real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 13 U.S. qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 14 U.S. qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 15 U.S. qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 16 U.S. real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 17 U.S. real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 18 U.S. real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 19 Canada real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 20 Canada real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 21 Canada qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 22 Canada qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 23 Canada qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 24 Canada real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 25 Canada real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 26 Canada real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 27 Europe real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 28 Europe real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 29 Europe qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 30 Europe qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 31 Europe qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 32 Europe real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 33 Europe real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 34 Europe real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 35 U.K. real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 36 U.K. real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 37 U.K. qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 38 U.K. qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 39 U.K. qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 40 U.K. real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 41 U.K. real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 42 U.K. real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 43 Germany real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 44 Germany real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 45 Germany qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 46 Germany qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 47 Germany qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 48 Germany real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 49 Germany real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 50 Germany real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 51 Italy real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 52 Italy real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 53 Italy qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 54 Italy qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 55 Italy qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 56 Italy real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 57 Italy real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 58 Italy real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 59 Spain real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 60 Spain real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 61 Spain qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 62 Spain qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 63 Spain qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 64 Spain real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 65 Spain real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 66 Spain real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 67 France real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 68 France real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 69 France qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 70 France qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 71 France qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 72 France real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 73 France real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 74 France real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 75 Denmark real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 76 Denmark real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 77 Denmark qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 78 Denmark qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 79 Denmark qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 80 Denmark real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 81 Denmark real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 82 Denmark real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 83 Sweden real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 84 Sweden real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 85 Sweden qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 86 Sweden qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 87 Sweden qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 88 Sweden real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 89 Sweden real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 90 Sweden real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 91 Norway real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 92 Norway real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 93 Norway qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 94 Norway qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 95 Norway qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 96 Norway real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 97 Norway real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 98 Norway real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 99 Asia-Pacific real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 100 Asia-Pacific real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 101 Asia-Pacific qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 102 Asia-Pacific qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 103 Asia-Pacific qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 104 Asia-Pacific real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 105 Asia-Pacific real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 106 Asia-Pacific real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 107 China real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 108 China real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 109 China qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 110 China qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 111 China qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 112 China real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 113 China real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 114 China real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 115 Japan real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 116 Japan real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 117 Japan qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 118 Japan qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 119 Japan qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 120 Japan real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 121 Japan real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 122 Japan real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 123 India real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 124 India real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 125 India qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 126 India qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 127 India qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 128 India real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 129 India real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 130 India real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 131 Australia real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 132 Australia real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 133 Australia qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 134 Australia qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 135 Australia qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 136 Australia real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 137 Australia real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 138 Australia real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 139 South Korea real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 140 South Korea real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 141 South Korea qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 142 South Korea qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 143 South Korea qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 144 South Korea real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 145 South Korea real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 146 South Korea
Table 147 Thailand real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 148 Thailand real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 149 Thailand qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 150 Thailand qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 151 Thailand qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 152 Thailand real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 153 Thailand real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 154 Thailand real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 155 Latin America real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 156 Latin America real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 157 Latin America qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 158 Latin America qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 159 Latin America qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 160 Latin America real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 161 Latin America real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 162 Latin America real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 163 Brazil real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 164 Brazil real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 165 Brazil qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 166 Brazil qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 167 Brazil qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 168 Brazil real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 169 Brazil real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 170 Brazil real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 171 Mexico real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 172 Mexico real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 173 Mexico qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 174 Mexico qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 175 Mexico qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 176 Mexico real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 177 Mexico real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 178 Mexico real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 179 Argentina real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 180 Argentina real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 181 Argentina qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 182 Argentina qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 183 Argentina qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 184 Argentina real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 185 Argentina real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 186 Argentina real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 187 MEA real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 188 MEA real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 189 MEA qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 190 MEA qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 191 MEA qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 192 MEA real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 193 MEA real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 194 MEA real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 195 South Africa real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 196 South Africa real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 197 South Africa qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 198 South Africa qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 199 South Africa qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 200 South Africa real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 201 South Africa real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 202 South Africa real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 203 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 204 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 205 Saudi Arabia qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 206 Saudi Arabia qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 207 Saudi Arabia qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 208 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 209 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 210 Saudi Arabia real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 211 UAE real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 212 UAE real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 213 UAE qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 214 UAE qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 215 UAE qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 216 UAE real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 217 UAE real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 218 UAE real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
Table 219 Kuwait real time PCR, digital PCR and end-point PCR market, by technology, 2018-2030 (USD Million)
Table 220 Kuwait real time PCR, digital PCR and end-point PCR market, by product, 2018-2030 (USD Million)
Table 221 Kuwait qPCR and dPCR consumables & reagents market, by technology, 2018-2030 (USD Million)
Table 222 Kuwait qPCR and dPCR instruments market, by technology, 2018-2030 (USD Million)
Table 223 Kuwait qPCR and dPCR software & services market, by technology, 2018-2030 (USD Million)
Table 224 Kuwait real time PCR, digital PCR and end-point PCR market, by application, 2018-2030 (USD Million)
Table 225 Kuwait real time PCR, digital PCR and end-point PCR market, by clinical application, 2018-2030 (USD Million)
Table 226 Kuwait real time PCR, digital PCR and end-point PCR market, by research application, 2018-2030 (USD Million)
List of Figures
Figure 1 Real-time PCR (qPCR), end point PCR, and dPCR market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Real-time PCR (qPCR), end point PCR, and dPCR market snapshot
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Real-time PCR (qPCR), end point PCR, and dPCR market driver impact
Figure 14 Real-time PCR (qPCR), end point PCR, and dPCR market restraint impact
Figure 15 SWOT analysis, by factor (Political & legal, economic, and technological)
Figure 16 Industry Analysis - Porter’s
Figure 17 Strategy mapping
Figure 18 Ansoff Matrix
Figure 19 Competitive dashboard analysis
Figure 20 Regional network map
Figure 21 Real-time PCR (qPCR), end point PCR, and dPCR market: Technology outlook and key takeaways
Figure 22 Real-time PCR (qPCR), end point PCR, and dPCR market: Technology movement analysis& market share 2023 & 2030
Figure 23 Quantitative market estimates and forecast, 2018-2030(USD Million)
Figure 24 Digital market estimates and forecast, 2018-2030 (USD Million)
Figure 25 End-point PCR market estimates and forecast, 2018-2030(USD Million)
Figure 26 Real-time PCR (qPCR), end point PCR, and dPCR market: Products outlook and key takeaways
Figure 27 Real-time PCR (qPCR), end point PCR, and dPCR market: Products movement analysis & market share 2023 & 2030
Figure 28 Consumables & reagents market estimates and forecast, 2018-2030 (USD Million)
Figure 29 Instruments market estimates and forecast, 2018-2030 (USD Million)
Figure 30 Software & services market estimates and forecast, 2018-2030 (USD Million)
Figure 31 Real-time PCR (qPCR), end point PCR, and dPCR market: Application outlook and key takeaways
Figure 32 Real-time PCR (qPCR), end point PCR, and dPCR market: Application movement analysis & market share 2023 & 2030
Figure 33 Clinical market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Pathogen testing market estimates and forecast, 2018-2030 (USD Million)
Figure 35 Oncology testing market estimates and forecast, 2018-2030 (USD Million)
Figure 36 Blood screening market estimates and forecast, 2018-2030 (USD Million)
Figure 37 Liquid Biopsy testing market estimates and forecast, 2018-2030 (USD Million)
Figure 38 dPCR-based Non-Invasive Prenatal Testing (NIPT) market estimates and forecast, 2018-2030 (USD Million)
Figure 39 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 40 Research market estimates and forecast, 2018-2030 (USD Million)
Figure 41 Stem cell research market estimates and forecast, 2018-2030 (USD Million)
Figure 42 DNA cloning & sequencing market estimates and forecast, 2018-2030 (USD Million)
Figure 43 Recombinant DNA technology market estimates and forecast, 2018-2030 (USD Million)
Figure 44 Rare mutation detection market estimates and forecast, 2018-2030 (USD Million)
Figure 45 Gene expression market estimates and forecast, 2018-2030 (USD Million)
Figure 46 Single-cell analysis market estimates and forecast, 2018-2030 (USD Million)
Figure 47 Microbiome analysis market estimates and forecast, 2018-2030 (USD Million)
Figure 48 Copy number variation analysis market estimates and forecast, 2018-2030 (USD Million)
Figure 49 Library quantification (NGS) market estimates and forecast, 2018-2030 (USD Million)
Figure 50 Characterization of low-fold changes in mRNA and miRNA expression market estimates and forecast, 2018-2030 (USD Million)
Figure 51 Species identification market estimates and forecast, 2018-2030 (USD Million)
Figure 52 GMO detection market estimates and forecast, 2018-2030 (USD Million)
Figure 53 Forensics and others market estimates and forecast, 2018-2030 (USD Million)
Figure 54 Real-time PCR (qPCR), end point PCR, and dPCR market: Regional outlook and key takeaways
Figure 55 Regional outlook, 2023 & 2030
Figure 56 North America
Figure 57 North America. market estimates and forecast, 2018-2030 (USD Million)
Figure 58 U.S.
Figure 59 U.S. market estimates and forecast, 2018-2030 (USD Million)
Figure 60 Canada
Figure 61 Canada market estimates and forecast, 2018-2030 (USD Million)
Figure 62 Europe
Figure 63 Europe market estimates and forecast, 2018-2030 (USD Million)
Figure 64 UK
Figure 65 UK market estimates and forecast, 2018-2030 (USD Million)
Figure 66 Germany
Figure 67 Germany market estimates and forecast, 2018-2030 (USD Million)
Figure 68 France
Figure 69 France market estimates and forecast, 2018-2030 (USD Million)
Figure 70 Italy
Figure 71 Italy market estimates and forecast, 2018-2030 (USD Million)
Figure 72 Spain
Figure 73 Spain market estimates and forecast, 2018-2030 (USD Million)
Figure 74 Denmark
Figure 75 Denmark market estimates and forecast, 2018-2030 (USD Million)
Figure 76 Sweden
Figure 77 Sweden market estimates and forecast, 2018-2030 (USD Million)
Figure 78 Norway
Figure 79 Norway market estimates and forecast, 2018-2030 (USD Million)
Figure 80 Asia-Pacific
Figure 81 Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Figure 82 Japan
Figure 83 Japan market estimates and forecast, 2018-2030(USD Million)
Figure 84 India
Figure 85 India. market estimates and forecast, 2018-2030 (USD Million)
Figure 86 China
Figure 87 China market estimates and forecast, 2018-2030 (USD Million)
Figure 88 Australia
Figure 89 Australia market estimates and forecast, 2018-2030 (USD Million)
Figure 90 South Korea
Figure 91 South Korea market estimates and forecast, 2018-2030 (USD Million)
Figure 92 Thailand
Figure 93 Thailand market estimates and forecast, 2018-2030 (USD Million)
Figure 94 Latin America
Figure 95 Latin America. market estimates and forecast, 2018-2030 (USD Million)
Figure 96 Brazil
Figure 97 Brazil market estimates and forecast, 2018-2030 (USD Million)
Figure 98 Mexico
Figure 99 Mexico market estimates and forecast, 2018-2030 (USD Million)
Figure 100 Argentina
Figure 101 Argentina market estimates and forecast, 2018-2030 (USD Million)
Figure 102 Middle East & Africa
Figure 103 MEA market estimates and forecast, 2018-2030 (USD Million)
Figure 104 South Africa
Figure 105 South Africa market estimates and forecast, 2018-2030 (USD Million)
Figure 106 Saudi Arabia
Figure 107 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Figure 108 UAE
Figure 109 UAE market estimates and forecast, 2018-2030 (USD Million)
Figure 110 Kuwait
Figure 111 Kuwait market estimates and forecast, 2018-2030 (USD Million)
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Real-time PCR (qPCR), end point PCR, and dPCR market snapshot
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Real-time PCR (qPCR), end point PCR, and dPCR market driver impact
Figure 14 Real-time PCR (qPCR), end point PCR, and dPCR market restraint impact
Figure 15 SWOT analysis, by factor (Political & legal, economic, and technological)
Figure 16 Industry Analysis - Porter’s
Figure 17 Strategy mapping
Figure 18 Ansoff Matrix
Figure 19 Competitive dashboard analysis
Figure 20 Regional network map
Figure 21 Real-time PCR (qPCR), end point PCR, and dPCR market: Technology outlook and key takeaways
Figure 22 Real-time PCR (qPCR), end point PCR, and dPCR market: Technology movement analysis& market share 2023 & 2030
Figure 23 Quantitative market estimates and forecast, 2018-2030(USD Million)
Figure 24 Digital market estimates and forecast, 2018-2030 (USD Million)
Figure 25 End-point PCR market estimates and forecast, 2018-2030(USD Million)
Figure 26 Real-time PCR (qPCR), end point PCR, and dPCR market: Products outlook and key takeaways
Figure 27 Real-time PCR (qPCR), end point PCR, and dPCR market: Products movement analysis & market share 2023 & 2030
Figure 28 Consumables & reagents market estimates and forecast, 2018-2030 (USD Million)
Figure 29 Instruments market estimates and forecast, 2018-2030 (USD Million)
Figure 30 Software & services market estimates and forecast, 2018-2030 (USD Million)
Figure 31 Real-time PCR (qPCR), end point PCR, and dPCR market: Application outlook and key takeaways
Figure 32 Real-time PCR (qPCR), end point PCR, and dPCR market: Application movement analysis & market share 2023 & 2030
Figure 33 Clinical market estimates and forecast, 2018-2030 (USD Million)
Figure 34 Pathogen testing market estimates and forecast, 2018-2030 (USD Million)
Figure 35 Oncology testing market estimates and forecast, 2018-2030 (USD Million)
Figure 36 Blood screening market estimates and forecast, 2018-2030 (USD Million)
Figure 37 Liquid Biopsy testing market estimates and forecast, 2018-2030 (USD Million)
Figure 38 dPCR-based Non-Invasive Prenatal Testing (NIPT) market estimates and forecast, 2018-2030 (USD Million)
Figure 39 Others market estimates and forecast, 2018-2030 (USD Million)
Figure 40 Research market estimates and forecast, 2018-2030 (USD Million)
Figure 41 Stem cell research market estimates and forecast, 2018-2030 (USD Million)
Figure 42 DNA cloning & sequencing market estimates and forecast, 2018-2030 (USD Million)
Figure 43 Recombinant DNA technology market estimates and forecast, 2018-2030 (USD Million)
Figure 44 Rare mutation detection market estimates and forecast, 2018-2030 (USD Million)
Figure 45 Gene expression market estimates and forecast, 2018-2030 (USD Million)
Figure 46 Single-cell analysis market estimates and forecast, 2018-2030 (USD Million)
Figure 47 Microbiome analysis market estimates and forecast, 2018-2030 (USD Million)
Figure 48 Copy number variation analysis market estimates and forecast, 2018-2030 (USD Million)
Figure 49 Library quantification (NGS) market estimates and forecast, 2018-2030 (USD Million)
Figure 50 Characterization of low-fold changes in mRNA and miRNA expression market estimates and forecast, 2018-2030 (USD Million)
Figure 51 Species identification market estimates and forecast, 2018-2030 (USD Million)
Figure 52 GMO detection market estimates and forecast, 2018-2030 (USD Million)
Figure 53 Forensics and others market estimates and forecast, 2018-2030 (USD Million)
Figure 54 Real-time PCR (qPCR), end point PCR, and dPCR market: Regional outlook and key takeaways
Figure 55 Regional outlook, 2023 & 2030
Figure 56 North America
Figure 57 North America. market estimates and forecast, 2018-2030 (USD Million)
Figure 58 U.S.
Figure 59 U.S. market estimates and forecast, 2018-2030 (USD Million)
Figure 60 Canada
Figure 61 Canada market estimates and forecast, 2018-2030 (USD Million)
Figure 62 Europe
Figure 63 Europe market estimates and forecast, 2018-2030 (USD Million)
Figure 64 UK
Figure 65 UK market estimates and forecast, 2018-2030 (USD Million)
Figure 66 Germany
Figure 67 Germany market estimates and forecast, 2018-2030 (USD Million)
Figure 68 France
Figure 69 France market estimates and forecast, 2018-2030 (USD Million)
Figure 70 Italy
Figure 71 Italy market estimates and forecast, 2018-2030 (USD Million)
Figure 72 Spain
Figure 73 Spain market estimates and forecast, 2018-2030 (USD Million)
Figure 74 Denmark
Figure 75 Denmark market estimates and forecast, 2018-2030 (USD Million)
Figure 76 Sweden
Figure 77 Sweden market estimates and forecast, 2018-2030 (USD Million)
Figure 78 Norway
Figure 79 Norway market estimates and forecast, 2018-2030 (USD Million)
Figure 80 Asia-Pacific
Figure 81 Asia-Pacific market estimates and forecast, 2018-2030 (USD Million)
Figure 82 Japan
Figure 83 Japan market estimates and forecast, 2018-2030(USD Million)
Figure 84 India
Figure 85 India. market estimates and forecast, 2018-2030 (USD Million)
Figure 86 China
Figure 87 China market estimates and forecast, 2018-2030 (USD Million)
Figure 88 Australia
Figure 89 Australia market estimates and forecast, 2018-2030 (USD Million)
Figure 90 South Korea
Figure 91 South Korea market estimates and forecast, 2018-2030 (USD Million)
Figure 92 Thailand
Figure 93 Thailand market estimates and forecast, 2018-2030 (USD Million)
Figure 94 Latin America
Figure 95 Latin America. market estimates and forecast, 2018-2030 (USD Million)
Figure 96 Brazil
Figure 97 Brazil market estimates and forecast, 2018-2030 (USD Million)
Figure 98 Mexico
Figure 99 Mexico market estimates and forecast, 2018-2030 (USD Million)
Figure 100 Argentina
Figure 101 Argentina market estimates and forecast, 2018-2030 (USD Million)
Figure 102 Middle East & Africa
Figure 103 MEA market estimates and forecast, 2018-2030 (USD Million)
Figure 104 South Africa
Figure 105 South Africa market estimates and forecast, 2018-2030 (USD Million)
Figure 106 Saudi Arabia
Figure 107 Saudi Arabia market estimates and forecast, 2018-2030 (USD Million)
Figure 108 UAE
Figure 109 UAE market estimates and forecast, 2018-2030 (USD Million)
Figure 110 Kuwait
Figure 111 Kuwait market estimates and forecast, 2018-2030 (USD Million)
Companies Mentioned
- Abbott
- Qiagen
- Bio-Rad Laboratories, Inc.
- Agilent Technologies, Inc.
- Thermo Fisher Scientific, Inc.
- Affymetrix
- Ge Healthcare
- Biomérieux Sa
- F. Hoffmann-La Roche Ltd
- Fluidigm Corporation
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | December 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 5.38 Billion |
| Forecasted Market Value ( USD | $ 7.18 Billion |
| Compound Annual Growth Rate | 4.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
